MicroRNA 548h-3 (MIR548H3)

MicroRNA 548h-3 (MIR548H3) is a member of the miR-548 family of microRNAs, which are short (20–24 nucleotide), non-coding RNAs involved in the post-transcriptional regulation of gene expression in multicellular organisms[4][5]. miR-548 family members, in general, participate in regulating cell proliferation, apoptosis, migration, and invasion, notably in cancer biology, but specific biological or disease roles for MIR548H3 itself are not well established in the literature[1]. There is currently limited direct evidence implicating MIR548H3 as an independent therapeutic target, biomarker, or molecule with specific interactions or mechanisms relevant to drug therapy. Context and further detail: - MicroRNAs (miRNAs) are not proteins, receptors, enzymes, or druggable targets in the conventional therapeutic sense, but rather act as negative regulators of gene expression by binding target mRNAs and preventing translation or promoting degradation[4][5]. - The biological and disease roles described above refer to the family (miR-548), not specifically to MIR548H3, for which detailed functional or therapeutic information is lacking in current databases and primary literature[1][4][5]. Summary of applicability: - No evidence was found that MIR548H3 is a receptor, enzyme, transporter, transcription factor, or conventional drug target. - No interacting drugs, mechanisms of action, biomarkers, or notable safety concerns are documented for MIR548H3. - MIR548H3 is best classified as a non-coding RNA (microRNA), involved in gene expression regulation, with broader disease associations inferred from the miR-548 family.

Other names

hsa-mir-548h-3MIR548H-3MIRN548H3